Endonovo Therapeutics, Inc.
ENDV· OTC
ENDVEndonovo Therapeutics, Inc.
Filed Dec 18, 2013 · 10-Q · 79 days after period end · 0001469709-13-000717
| Metric | Q3 2013 | Q3 2012 |
|---|---|---|
| Revenue | $0.00 | $7.16K |
| Net Income | -$452.40K | -$392.90K |
| EPS Diluted | -$0.01 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Endonovo Therapeutics, Inc. · CIK 1528172 · Engraved from SEC EDGAR
ended Sep 30, 2013 · filed Dec 18, 2013 · 79 d after period end
